Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 187  
This article has been cited by
1A microdose clinical trial to evaluate [18F]Florastamin as a positron emission tomography imaging agent in patients with prostate cancer
Inki Lee,Ilhan Lim,Byung Hyun Byun,Byung Il Kim,Chang Woon Choi,Sang-Keun Woo,Kyo Chul Lee,Joo Hyun Kang,Hee Seup Kil,Chansoo Park,Dae Yoon Chi,Jongwook Park,Kanghyon Song,Sang Moo Lim
European Journal of Nuclear Medicine and Molecular Imaging.2021;48(1)95
[DOI]
2Expert Group Consensus Opinion on Prostate Cancer Diagnosis and Management in India: Part 2 of 2
Amit Ghose,Makarand Khochikar,Ravindra Sabnis,Naveen Magendra Parmar,Indranil Purkait
The Korean Journal of Urological Oncology.2021;19(1)1
[DOI]
3Clinical Impact of PET Imaging in Patients With Metastatic Prostate Cancer
Murat Tuncel,Meltem Çaglar Tuncali,Tugçe Telli,Mustafa Erman
Clinical Nuclear Medicine.2020;45(10)757
[DOI]
499MTc-PSMA – radionuclide imaging of prostate cancer: an innovative diagnostic direction in nuclear medicine
P. Korol,M. Tkachenko,A. Voloshin
Radiation Diagnostics, Radiation Therapy.2020;45(3)26
[DOI]
5Use and Impact of Positron Emission Tomography/Computed Tomography Prior to Salvage Radiation Therapy in Men with Biochemical Recurrence After Radical Prostatectomy: A Scoping Review
Luca Valle,David Shabsovich,Gert de Meerleer,Tobias Maurer,Declan G. Murphy,Nicholas G. Nickols,Neha Vapiwala,Jeremie Calais,Amar U. Kishan
European Urology Oncology.2021;4(3)339
[DOI]
  Feedback 
  Subscribe 

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal